Autolus Therapeutics PLC expected to post a loss of 46  cents a share - Earnings Preview

Autolus Therapeutics

08/03/2022 14:57

* Autolus Therapeutics PLC  AUTL.OQ   AUTL.O  is expected
to show
a fall in quarterly revenue when it reports  results on March
10. 
    * The London United Kingdom-based   company is expected to
report 
a 51.2% decrease in revenue to $197 thousand from $404 thousand
a year ago, according to the mean estimate from 7 analysts,
based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Autolus
Therapeutics PLC
is for a loss of 46 cents per share. For the same quarter last
year, the company reported a loss of 83 cents per share.
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 8 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Autolus
Therapeutics PLC is $13​, about 72.9% above​ its last closing
price of $3.52. ​​​
    * Previous quarterly performance (using preferred earnings
measure
in US dollars). ​

 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Sep. 30 2021  -0.52       -0.51      -0.47     Beat    7
 Jun. 30 2021  -0.50       -0.50      -0.47     Beat    5.8
 Mar. 31 2021  -0.61       -0.60      -0.52     Beat    14​
 Dec. 31 2020  -0.78       -0.77      -0.83     Missed  -8.4
 ​​Sep.        -0.70       -0.71      -0.72     Missed  -1.9
 30 2020                                                
 Jun. 30 2020  -0.70       -0.71      -0.62     Beat    12.5​
 Mar. 31 2020  -0.76       -0.74      -0.60     Beat    19.1
 Dec. 31 2019  -0.72       -0.74      -0.84     Missed  -13.8
 This summary was machine generated March 8 at 14:57 GMT.  All
figures in US dollars  unless otherwise stated